|
Mycobacterium M. abscessus, M. africanum, M. alvei, M. asiaticum, M. aurum, M. avium, M. bohemicum, M. bovis, M. branderi, M. brumae, M. celatum, M. chelonae, M. chubense, M. confluentis, M. conspicuum, M. cookii, M. flavescens, M. fortuitum, M. gadium, M. gastri, M. genavense, M. gordonae, M. goodii, M. haemophilum, M. hassicum, M. intracellulare, M. interjectum, M. heidelberense, M. kansasii, M. lentiflavum, M. leprae, M. malmoense, M. marinum, M. microgenicum, M. microti, M. mucogenicum, M. neoaurum, M. nonchromogenicum, M. peregrinum, M. phlei, M. scrofulaceum, M. shimoidei, M. simiae, M. smegmatis, M. szulgai, M. terrae, M. thermoresistabile, M. triplex, M. triviale, M. tuberculosis, M. tusciae, M. ulcerans, M. vaccae, M. wolinskyi, M. xenopi - are spp. reported to be associated with infections in humans
Agents of tuberculosis are M. tuberculosis, M. bovis, M. africanum - therapeutic agents - isoniazid, rifampicin, ethambutol, pyrazinamide, streptomycin - susceptibility variable
M. leprae - associated with leprosy - therapeutic agents, dapsone,rifampicin, clofazimine
M. scrofulaceum - associated with cervical adenitis
M. ulcerans - associated with Buruli ulcer
M. marinum - associated with fish-tank granuloma
M. malmoense, M. szulgai, M. kansasii, M. xenopi - associated with pulmonary infection
M. intracellulare, M. avium - associated with systemic infection in imunocompromised patients - therapeutic agents macrolides, fluoroquinolones, anti-TB agents
"Rapid growers" - M. abscessus, M. chelonae, M. fortuitum - associated with post-inoculation infection, pulmonary and systemic infection - therapeutic agents - co-trimoxazole, imipenem, amikacin
Reference - Falkinham, J.O. 3rd. (1996). Epidemiology of infection by nontuberculous mycobacteria. Clin. microbiol. Rev.9, 177-215.
|
|